HUP0400856A2 - Gombaellenes készítmény - Google Patents

Gombaellenes készítmény

Info

Publication number
HUP0400856A2
HUP0400856A2 HU0400856A HUP0400856A HUP0400856A2 HU P0400856 A2 HUP0400856 A2 HU P0400856A2 HU 0400856 A HU0400856 A HU 0400856A HU P0400856 A HUP0400856 A HU P0400856A HU P0400856 A2 HUP0400856 A2 HU P0400856A2
Authority
HU
Hungary
Prior art keywords
compound
formula
antifungal composition
mammals
prevention
Prior art date
Application number
HU0400856A
Other languages
English (en)
Inventor
David Harris
Shashank Mahashabde
Joel Sequeira
Stefan Sharpe
Original Assignee
Schering Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23076102&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0400856(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp. filed Critical Schering Corp.
Publication of HUP0400856A2 publication Critical patent/HUP0400856A2/hu
Publication of HUP0400856A3 publication Critical patent/HUP0400856A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/64—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
    • A01N43/647—Triazoles; Hydrogenated triazoles
    • A01N43/653—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dentistry (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Dispersion Chemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A találmány szerinti stabil folyékony szuszpenziók az (I) képletűvegyület gombaellenes szerként hatásos mennyiségét tartalmazzák,valamint legalább egy sűrítőszert, egy nemionos felületaktív anyagotés egy pufferrendszert egy gyógyszerészetileg elfogadhatóvivőanyagban. A találmány tárgya továbbá az (I) képletű vegyületalkalmazása emlősök gombafertőzéseinek kezelésére és/vagy megelőzéséreszolgáló orális, szuszpenzió formájú gyógyszer készítésére. Ó
HU0400856A 2001-04-03 2002-04-01 Antifungal composition HUP0400856A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28113901P 2001-04-03 2001-04-03
PCT/US2002/010093 WO2002080678A1 (en) 2001-04-03 2002-04-01 Antifungal composition with enhanced bioavailability

Publications (2)

Publication Number Publication Date
HUP0400856A2 true HUP0400856A2 (hu) 2004-08-30
HUP0400856A3 HUP0400856A3 (en) 2012-09-28

Family

ID=23076102

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0400856A HUP0400856A3 (en) 2001-04-03 2002-04-01 Antifungal composition

Country Status (18)

Country Link
US (2) US20030055067A1 (hu)
EP (2) EP2090165A3 (hu)
JP (2) JP4308902B2 (hu)
KR (1) KR100607742B1 (hu)
CN (1) CN100415234C (hu)
AR (1) AR033096A1 (hu)
AU (1) AU2002257104B2 (hu)
BR (1) BR0208626A (hu)
CA (1) CA2443089C (hu)
HU (1) HUP0400856A3 (hu)
MX (1) MXPA03009021A (hu)
NO (1) NO20034419L (hu)
NZ (1) NZ528363A (hu)
PE (1) PE20020994A1 (hu)
PL (1) PL212985B1 (hu)
TW (1) TWI311464B (hu)
WO (1) WO2002080678A1 (hu)
ZA (1) ZA200307684B (hu)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030072807A1 (en) * 2000-12-22 2003-04-17 Wong Joseph Chung-Tak Solid particulate antifungal compositions for pharmaceutical use
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
BR0212833A (pt) 2001-09-26 2004-10-13 Baxter Int Preparação de nanopartìculas de tamanho submìcron através de dispersão e de remoção de solvente ou de fase lìquida
JP2008501034A (ja) * 2004-05-28 2008-01-17 シェーリング　コーポレイション ポサコナゾールを含む注射用薬学的懸濁液
US20060009469A1 (en) * 2004-05-28 2006-01-12 Leonore Witchey-Lakshmanan Particulate-stabilized injectable pharmacutical compositions of posaconazole
US20060160823A1 (en) * 2004-05-28 2006-07-20 Leonore Witchey-Lakshmanan Particulate-stabilized injectable pharmaceutical compositions of Posaconazole
US7473684B2 (en) * 2005-09-16 2009-01-06 Selamine Limited Bisphosphonate formulation
BRPI0712130A2 (pt) 2006-05-30 2012-01-17 Elan Pharma Int Ltd formulações de posaconazol em nanopartìculas
AR061351A1 (es) 2006-06-14 2008-08-20 Intervet Int Bv Composicion de carbamato de bencimidazol
GB0624084D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amino acid salts
GB0624087D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
GB0624090D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amine salts
FR2910323A1 (fr) * 2006-12-26 2008-06-27 Virbac Sa Sa Composition liquide anhydre destinee a etre incorporee a l'eau de boisson des animaux d'elevage.
DE102008004893A1 (de) 2008-01-17 2009-07-23 Add Technologies Ltd. Trägerpellets, Verfahren zu deren Herstellung und deren Verwendung
WO2009129301A2 (en) * 2008-04-15 2009-10-22 Schering Corporation Oral pharmaceutical compositions in a molecular solid dispersion
EP2285351A2 (en) * 2008-04-15 2011-02-23 Schering Corporation Oral pharmaceutical compositions in a solid dispersion comprising preferably posaconazole and hpmcas
EP2130540A1 (en) * 2008-06-02 2009-12-09 Sandoz AG Pharmaceutical compositions containing a crystalline form of posaconazole
EP2141159A1 (en) 2008-07-03 2010-01-06 Sandoz AG A Crystalline form of posaconazole
US20120101277A1 (en) 2009-07-09 2012-04-26 Sandoz Ag Crystalline form of posaconazole
US9040539B2 (en) 2010-05-19 2015-05-26 Sandoz Ag Process for the preparation of chiral triazolones
CN102892763B (zh) 2010-05-19 2016-03-09 桑多斯股份公司 泊沙康唑及泊沙康唑中间体的纯化
MX338514B (es) 2010-05-19 2016-04-20 Sandoz Ag Preparacion de intermediarios de posaconazol.
CN102892750B (zh) 2010-05-19 2016-03-02 桑多斯股份公司 制备手性酰肼的方法
CN103635465A (zh) 2011-06-16 2014-03-12 桑多斯股份公司 制备手性化合物的方法
CA2874797A1 (en) 2012-06-14 2013-12-19 Sandoz Ag Pharmaceutical composition comprising crystalline posaconazole
CN112375073B (zh) 2014-12-05 2024-04-16 普尔莫赛德有限公司 抗真菌的化合物
HUE048843T2 (hu) * 2015-05-21 2020-08-28 Pulmocide Ltd Gombaölõ szer 4-(4-(4-(((3R,5R)-5-((1H -1,2,4-triazol-1-YL)metil)-5-(2,4-difluor-fenil)tetra-hidro-furán-3-YL)metoxi)-3 metilfenil)piperazin-1-il)-n -(2-hidroxi-ciklohexil)benzamid, vagy annak gyógyszerészetileg elfogadható sója
CN105030668B (zh) * 2015-06-26 2018-03-27 济川药业集团有限公司 泊沙康唑口服混悬剂及其制备方法
CN106333925B (zh) * 2015-07-10 2019-06-18 上海美悦生物科技发展有限公司 一种泊沙康唑液体混悬剂及其制备方法
US10464922B2 (en) 2015-12-30 2019-11-05 Nqp 1598, Ltd. Metalloenzyme inhibitor compounds
CN106389390A (zh) * 2016-06-30 2017-02-15 重庆华邦制药有限公司 泊沙康唑涂膜剂及其制备方法
CN107625729A (zh) * 2017-09-29 2018-01-26 重庆华邦制药有限公司 泊沙康唑口服混悬液及其制备方法
CN110507609B (zh) * 2018-05-21 2021-09-17 上海医药工业研究院 泊沙康唑口服混悬剂的制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4533254A (en) 1981-04-17 1985-08-06 Biotechnology Development Corporation Apparatus for forming emulsions
US4788220A (en) * 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions
NZ234143A (en) * 1989-06-28 1991-10-25 Mcneil Ppc Inc Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
AU642066B2 (en) 1991-01-25 1993-10-07 Nanosystems L.L.C. X-ray contrast compositions useful in medical imaging
US5552160A (en) 1991-01-25 1996-09-03 Nanosystems L.L.C. Surface modified NSAID nanoparticles
US5399363A (en) 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
HU225062B1 (en) * 1993-12-21 2006-05-29 Schering Corp Tetrahydrofuran derivatives with antifungal- effect, pharmaceutical compositions containing them and process for their preparation
US5661151A (en) * 1993-12-21 1997-08-26 Schering Corporation Tetrahydrofuran antifungals
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
US5580579A (en) * 1995-02-15 1996-12-03 Nano Systems L.L.C. Site-specific adhesion within the GI tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymers
AU7587496A (en) * 1995-11-20 1997-06-11 Banyu Pharmaceutical Co., Ltd. Antifungal composition
US5834472A (en) * 1996-05-24 1998-11-10 Schering Corporation Antifungal composition with enhanced bioavailability
US5846971A (en) 1996-06-28 1998-12-08 Schering Corporation Oral antifungal composition
WO1998051281A1 (fr) * 1997-05-14 1998-11-19 Senju Pharmaceutical Co., Ltd. Preparations a base de suspensions aqueuses possedant d'excellentes proprietes de redispersion
CA2333648C (en) 1998-05-29 2008-10-21 Rtp Pharma Inc. Thermoprotected microparticle compositions and process for terminal steam sterilization thereof
US20050048126A1 (en) * 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug

Also Published As

Publication number Publication date
NO20034419L (no) 2003-12-02
JP2008120836A (ja) 2008-05-29
US8263600B2 (en) 2012-09-11
CN1499930A (zh) 2004-05-26
CA2443089C (en) 2011-11-01
TWI311464B (en) 2009-07-01
KR20030087052A (ko) 2003-11-12
JP2004527525A (ja) 2004-09-09
EP2090165A3 (en) 2012-03-28
PL212985B1 (pl) 2012-12-31
US20110244004A1 (en) 2011-10-06
EP2090165A2 (en) 2009-08-19
NO20034419D0 (no) 2003-10-02
AU2002257104B2 (en) 2006-02-09
CA2443089A1 (en) 2002-10-17
PL363965A1 (en) 2004-11-29
MXPA03009021A (es) 2004-02-12
WO2002080678A1 (en) 2002-10-17
EP1372394A1 (en) 2004-01-02
CN100415234C (zh) 2008-09-03
US20030055067A1 (en) 2003-03-20
ZA200307684B (en) 2005-03-30
BR0208626A (pt) 2004-03-09
AR033096A1 (es) 2003-12-03
JP4308902B2 (ja) 2009-08-05
KR100607742B1 (ko) 2006-08-01
NZ528363A (en) 2005-04-29
PE20020994A1 (es) 2002-11-01
HUP0400856A3 (en) 2012-09-28

Similar Documents

Publication Publication Date Title
HUP0400856A2 (hu) Gombaellenes készítmény
HUP0103319A2 (hu) Készítmények HIV- és egyéb vírusfertőzések kezelésére és alkalmazásuk
UA88463C2 (ru) Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции
TNSN07235A1 (en) Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride
SE0102315D0 (sv) Compounds
ATE286500T1 (de) 1,2,3,4-tetrahydroisochinolin-derivate
DK1401501T3 (da) Orale farmaceutiske sammensætninger med modificeret frigivelse af den aktive ingrediens
ES2178036T3 (es) Derivados de ciclosporina, su preparacion y las composiciones farmaceuticas que le contienen.
DE602004026053D1 (hu)
MA27040A1 (fr) Nucleosides substitues en 4'
WO2002062290A3 (en) Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
HUP0203028A2 (hu) Tolterodint tartalmazó gyógyszerkészítmény és alkalmazása
ATE332301T1 (de) Antivirale pyrazolopyridin verbindungen
TR200101499T1 (tr) Azepinoindol türevleri, hazırlanmaları ve kullanımları.
WO2003053344A3 (en) Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents
GB0011203D0 (en) Chemical compounds
HUP0103781A2 (hu) Megismerési képesség javítására szolgáló gyógyszerkészítmények, melyek atipikus antipszihotikus szer és acetilkolinészteráz inhibitor kombinációját tartalmazzák
HUP0102515A2 (hu) Ciklopeptidek, eljárás előállításukra, hatóanyagként azokat tartalmazó gyógyszerkészítmények és alkalmazásuk
AU2005099A (en) Methods and compositions for the treatment and prevention of (staphylococcus aureus) infections
ES2186550A1 (es) Nuevos derivados de oxazolidinonas como antibacterianos.
MXPA04006041A (es) Antivirales de piridoquinoxalina.
WO2003002064A3 (en) Fused pyrimidine dhfr inhibitors as antibacterials
MXPA03010054A (es) Composiciones que comprenden lopinavir y metodos para aumentar la biodisponibilidad de agentes farmaceuticos.
MXPA04001252A (es) Nuevos heterociclos benzo-fusionados como antagonistas de endotelina.
MXPA03000606A (es) Derivados de benzofurano y su uso como agentes antibacterianos.

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: MERCK SHARP & DOHME CORP., US

Free format text: FORMER OWNER(S): SCHERING CORP., US

FC4A Lapse of provisional application due to refusal